Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Dean Liu
+ 893 word(s) 893 2020-12-15 07:58:13

Video Upload Options

Do you have a full video?
Send video materials Upload full video

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Liu, D. KCNQ1 Gene. Encyclopedia. Available online: https://encyclopedia.pub/entry/4299 (accessed on 26 April 2024).
Liu D. KCNQ1 Gene. Encyclopedia. Available at: https://encyclopedia.pub/entry/4299. Accessed April 26, 2024.
Liu, Dean. "KCNQ1 Gene" Encyclopedia, https://encyclopedia.pub/entry/4299 (accessed April 26, 2024).
Liu, D. (2020, December 23). KCNQ1 Gene. In Encyclopedia. https://encyclopedia.pub/entry/4299
Liu, Dean. "KCNQ1 Gene." Encyclopedia. Web. 23 December, 2020.
KCNQ1 Gene
Edit
This entry is adapted from the peer-reviewed paper https://medlineplus.gov/genetics/gene/kcnq1

Potassium voltage-gated channel subfamily Q member 1

genes

1. Introduction

The KCNQ1 gene belongs to a large family of genes that provide instructions for making potassium channels. These channels, which transport positively charged atoms (ions) of potassium out of cells, play key roles in a cell's ability to generate and transmit electrical signals.

The specific function of a potassium channel depends on its protein components and its location in the body. Channels made with KCNQ1 proteins are primarily found in the inner ear and in heart (cardiac) muscle. In the inner ear, these channels help maintain the proper ion balance needed for normal hearing. In the heart, the channels are involved in recharging the cardiac muscle after each heartbeat to maintain a regular rhythm. The KCNQ1 protein is also produced in the kidney, lung, stomach, and intestine.

The KCNQ1 protein interacts with proteins in the KCNE family (such as the KCNE1 protein) to form functional potassium channels. Four alpha subunits made from KCNQ1 proteins form the structure of each channel. One beta subunit, made from a KCNE protein, attaches (binds) to the channel and regulates its activity.

2. Health Conditions Related to Genetic Changes

2.1. Familial Atrial Fibrillation

Changes in the KCNQ1 gene are an uncommon cause of familial atrial fibrillation, a disruption of the heart's normal rhythm (arrhythmia) characterized by uncoordinated electrical activity in the heart's upper chambers (the atria). Several mutations have been found to cause the condition; these genetic changes alter single protein building blocks (amino acids) in the KCNQ1 protein. In cardiac muscle cells, the mutations appear to increase the flow of potassium ions through the channel formed with the KCNQ1 protein. The enhanced ion transport can disrupt the heart's normal rhythm, resulting in atrial fibrillation.

2.2. Jervell and Lange-Nielsen Syndrome

More than 30 KCNQ1 gene mutations have been found to cause Jervell and Lange-Nielsen syndrome, a condition that causes arrhythmia and profound hearing loss from birth. About 90 percent of cases are caused by mutations in this gene. These mutations are typically present in both copies of the KCNQ1 gene in each cell. Most of these changes lead to the production of an abnormally short, nonfunctional version of the KCNQ1 protein that cannot be used to build potassium channels. Other mutations change a small number of amino acids in this protein, which alters the normal structure and function of the channels. An inability of these channels to properly transport potassium ions in the inner ear and cardiac muscle leads to the hearing loss and arrhythmia characteristic of Jervell and Lange-Nielsen syndrome.

2.3. Romano-Ward Syndrome

Mutations in the KCNQ1 gene are thought to be the most common cause of Romano-Ward syndrome, accounting for approximately one-third of cases. This condition is a form of arrhythmia called long QT syndrome. In people with Romano-Ward syndrome, the heart muscle takes longer than usual to recharge between beats.

More than 600 KCNQ1 gene mutations that cause Romano-Ward syndrome have been identified. The mutations that cause Romano-Ward syndrome are typically present in only one copy of the KCNQ1 gene in each cell. Most of these mutations change single amino acids in the KCNQ1 protein or insert or delete a small number of amino acids. These changes allow the protein to form channels but reduce the channels' ability to transport potassium ions out of cardiac muscle cells. The reduced ion transport alters the transmission of electrical signals in the heart, increasing the risk of an irregular heartbeat that can cause fainting (syncope) or sudden death.

2.4. Short QT Syndrome

At least two mutations in the KCNQ1 gene can cause a heart condition called short QT syndrome. In people with this condition, the cardiac muscle takes less time than usual to recharge between beats. This change increases the risk of an abnormal heart rhythm that can cause syncope or sudden death.

The KCNQ1 gene mutations associated with short QT syndrome change single amino acids in the KCNQ1 protein. The mutations alter the function of ion channels made with the KCNQ1 protein, increasing the channels' activity. As a result, more potassium ions flow out of cardiac muscle cells at a critical time during the heartbeat, which can lead to an irregular heart rhythm.

2.5. Other Disorders

Mutations in the KCNQ1 gene have been associated with several other conditions related to heart rhythm abnormalities, including sudden infant death syndrome (SIDS) and acquired long QT syndrome.

SIDS is a major cause of death in babies younger than one year. It is characterized by sudden and unexplained death, usually during sleep. Although the cause of SIDS is often unknown, researchers have identified mutations in the KCNQ1 gene in a few cases of this condition. Other genetic and environmental factors, many of which have not been identified, also play a part in determining the risk of SIDS.

Certain drugs, including medications used to treat arrhythmias, infections, seizures, and psychotic disorders, can lead to an abnormal heart rhythm in some people. This drug-induced heart condition, which is known as acquired long QT syndrome, increases the risk of cardiac arrest and sudden death. A small percentage of cases of acquired long QT syndrome occur in people who have an underlying variation in the KCNQ1 gene.

3. Other Names for This Gene

  • ATFB1

  • IKs producing slow voltage-gated potassium channel alpha subunit KvLQT1

  • JLNS1

  • KCNA8

  • KCNA9

  • KCNQ1_HUMAN

  • KQT-like 1

  • Kv1.9

  • Kv7.1

  • KVLQT1

  • LQT1

  • potassium channel, voltage gated KQT-like subfamily Q, member 1

  • potassium voltage-gated channel, KQT-like subfamily, member 1

References

  1. Alders M, Bikker H, Christiaans I. Long QT Syndrome. 2003 Feb 20 [updated 2018Feb 8]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K,Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University ofWashington, Seattle; 1993-2020. Available fromhttp://www.ncbi.nlm.nih.gov/books/NBK1129/
  2. Arnestad M, Crotti L, Rognum TO, Insolia R, Pedrazzini M, Ferrandi C, Vege A, Wang DW, Rhodes TE, George AL Jr, Schwartz PJ. Prevalence of long-QT syndromegene variants in sudden infant death syndrome. Circulation. 2007 Jan23;115(3):361-7.
  3. Bellocq C, van Ginneken AC, Bezzina CR, Alders M, Escande D, Mannens MM, Baró I, Wilde AA. Mutation in the KCNQ1 gene leading to the short QT-intervalsyndrome. Circulation. 2004 May 25;109(20):2394-7.
  4. Chan PJ, Osteen JD, Xiong D, Bohnen MS, Doshi D, Sampson KJ, Marx SO, KarlinA, Kass RS. Characterization of KCNQ1 atrial fibrillation mutations revealsdistinct dependence on KCNE1. J Gen Physiol. 2012 Feb;139(2):135-44. doi:10.1085/jgp.201110672.
  5. Ellinor PT, Moore RK, Patton KK, Ruskin JN, Pollak MR, Macrae CA. Mutations inthe long QT gene, KCNQ1, are an uncommon cause of atrial fibrillation. Heart.2004 Dec;90(12):1487-8.
  6. Herbert E, Trusz-Gluza M, Moric E, Smiłowska-Dzielicka E, Mazurek U, WilczokT. KCNQ1 gene mutations and the respective genotype-phenotype correlations in thelong QT syndrome. Med Sci Monit. 2002 Oct;8(10):RA240-8. Review.
  7. Hong K, Piper DR, Diaz-Valdecantos A, Brugada J, Oliva A, Burashnikov E,Santos-de-Soto J, Grueso-Montero J, Diaz-Enfante E, Brugada P, Sachse F,Sanguinetti MC, Brugada R. De novo KCNQ1 mutation responsible for atrialfibrillation and short QT syndrome in utero. Cardiovasc Res. 2005 Dec1;68(3):433-40.
  8. Huang L, Bitner-Glindzicz M, Tranebjaerg L, Tinker A. A spectrum of functionaleffects for disease causing mutations in the Jervell and Lange-Nielsen syndrome. Cardiovasc Res. 2001 Sep;51(4):670-80.
  9. Ioakeimidis NS, Papamitsou T, Meditskou S, Iakovidou-Kritsi Z. Sudden infantdeath syndrome due to long QT syndrome: a brief review of the genetic substrateand prevalence. J Biol Res (Thessalon). 2017 Mar 14;24:6. doi:10.1186/s40709-017-0063-1.
  10. Jespersen T, Grunnet M, Olesen SP. The KCNQ1 potassium channel: from gene tophysiological function. Physiology (Bethesda). 2005 Dec;20:408-16. Review.
  11. Melman YF, Um SY, Krumerman A, Kagan A, McDonald TV. KCNE1 binds to the KCNQ1 pore to regulate potassium channel activity. Neuron. 2004 Jun 24;42(6):927-37.
  12. Park KH, Piron J, Dahimene S, Mérot J, Baró I, Escande D, Loussouarn G.Impaired KCNQ1-KCNE1 and phosphatidylinositol-4,5-bisphosphate interactionunderlies the long QT syndrome. Circ Res. 2005 Apr 15;96(7):730-9.
  13. Paulussen AD, Gilissen RA, Armstrong M, Doevendans PA, Verhasselt P, SmeetsHJ, Schulze-Bahr E, Haverkamp W, Breithardt G, Cohen N, Aerssens J. Geneticvariations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QTsyndrome patients. J Mol Med (Berl). 2004 Mar;82(3):182-8.
  14. Tranebjærg L, Samson RA, Green GE. Jervell and Lange-Nielsen Syndrome. 2002Jul 29 [updated 2017 Aug 17]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE,Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020. Available fromhttp://www.ncbi.nlm.nih.gov/books/NBK1405/
  15. Tristani-Firouzi M, Sanguinetti MC. Structural determinants and biophysicalproperties of HERG and KCNQ1 channel gating. J Mol Cell Cardiol. 2003Jan;35(1):27-35. Review.
  16. Wang Z, Li H, Moss AJ, Robinson J, Zareba W, Knilans T, Bowles NE, Towbin JA. Compound heterozygous mutations in KvLQT1 cause Jervell and Lange-Nielsensyndrome. Mol Genet Metab. 2002 Apr;75(4):308-16.
More
©Text is available under the terms and conditions of the Creative Commons-Attribution ShareAlike (CC BY-SA) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Genetics & Heredity
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Dean Liu
View Times: 352
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 23 Dec 2020
Table of Contents
    1000/1000
    Hot Most Recent
    Feedback